Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2020-06-16 | 2020-06-15 |
| Drug Identification Number | 02382849 | 02382849 |
| Brand name | GLYCOPYRROLATE INJECTION MULTIDOSE | GLYCOPYRROLATE INJECTION MULTIDOSE |
| Common or Proper name | Glycopyrrolate Injection Multidose | Glycopyrrolate Injection Multidose |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | GLYCOPYRROLATE | GLYCOPYRROLATE |
| Strength(s) | 0.2MG | 0.2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 1 x 20mL vial / fiole | 1 x 20mL vial / fiole |
| ATC code | A03AB | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2020-03-17 | 2020-03-17 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2020-06-15 | 2020-06-15 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Preventive Allocation (COVID-19) | Preventive Allocation (COVID-19) |
| Health Canada comments |